| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9968 |
| Human Intestinal Absorption | HIA+ | 1.0000 |
| Caco-2 Permeability | Caco2+ | 0.5370 |
| P-glycoprotein Substrate | Non-substrate | 0.8596 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9065 |
| Non-inhibitor | 0.9718 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9192 |
| Distribution |
| Subcellular localization | Mitochondria | 0.5864 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8384 |
| CYP450 2D6 Substrate | Non-substrate | 0.7902 |
| CYP450 3A4 Substrate | Non-substrate | 0.6556 |
| CYP450 1A2 Inhibitor | Inhibitor | 0.7097 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.8311 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.8892 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.7802 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9476 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8279 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9712 |
| Non-inhibitor | 0.9619 |
| AMES Toxicity | Non AMES toxic | 0.5000 |
| Carcinogens | Non-carcinogens | 0.7538 |
| Fish Toxicity | Low FHMT | 0.7661 |
| Tetrahymena Pyriformis Toxicity | Low TPT | 0.8582 |
| Honey Bee Toxicity | High HBT | 0.6111 |
| Biodegradation | Ready biodegradable | 0.6775 |
| Acute Oral Toxicity | III | 0.7783 |
| Carcinogenicity (Three-class) | Warning | 0.5229 |